Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Second primary malignancies in multiple myeloma: an overview and IMWG consensus.

Literature DB >> 28541409

Second primary malignancies in multiple myeloma: an overview and IMWG consensus.

P Musto, K C Anderson, M Attal, P G Richardson, A Badros, J Hou, R Comenzo, J Du, B G M Durie, J San Miguel, H Einsele, W M Chen, L Garderet, G Pietrantuono, J Hillengass, R A Kyle, P Moreau, J J Lahuerta, O Landgren, H Ludwig, A Larocca, A Mahindra, M Cavo, A Mazumder, P L McCarthy, A Nouel, S V Rajkumar, A Reiman, E Riva, O Sezer, E Terpos, I Turesson, S Usmani, B M Weiss, A Palumbo.

Abstract

Entities: Disease

Year: 2018 PMID： 28541409 DOI： 10.1093/annonc/mdx160

Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976

Keyword Cloud
Cited

× No keyword cloud information.

6 in total

1. Selective targeting of multiple myeloma by B cell maturation antigen (BCMA)-specific central memory CD8⁺ cytotoxic T lymphocytes: immunotherapeutic application in vaccination and adoptive immunotherapy.

Authors: Jooeun Bae; Mehmet Samur; Paul Richardson; Nikhil C Munshi; Kenneth C Anderson
Journal: Leukemia Date: 2019-03-12 Impact factor: 11.528

2. Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation-study on behalf of CMWP of the EBMT.

Authors: Joanna Drozd-Sokołowska; Luuk Gras; Nienke Zinger; John A Snowden; Mutlu Arat; Grzegorz Basak; Anastasia Pouli; Charles Crawley; Keith M O Wilson; Herve Tilly; Jennifer Byrne; Claude Eric Bulabois; Jakob Passweg; Zubeyde Nur Ozkurt; Wilfried Schroyens; Bruno Lioure; Mercedes Colorado Araujo; Xavier Poiré; Gwendolyn Van Gorkom; Gunhan Gurman; Liesbeth C de Wreede; Patrick J Hayden; Meral Beksac; Stefan O Schönland; Ibrahim Yakoub-Agha
Journal: Bone Marrow Transplant Date: 2022-02-15 Impact factor: 5.483

6. Induction of cell cycle arrest and apoptosis by CPUC002 through stabilization of p53 and suppression of STAT3 signaling pathway in multiple myeloma.

Authors: Yue Zhao; Dongsheng Bai; Jiaying Du; Haochuan Ren; Zhenguo Zhang; Cheng Jiang; Na Lu
Journal: Cell Biol Toxicol Date: 2020-10-30 Impact factor: 6.691

6 in total

Second primary malignancies in multiple myeloma: an overview and IMWG consensus.

1. Selective targeting of multiple myeloma by B cell maturation antigen (BCMA)-specific central memory CD8⁺ cytotoxic T lymphocytes: immunotherapeutic application in vaccination and adoptive immunotherapy.

2. Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation-study on behalf of CMWP of the EBMT.

3. Therapy-related myeloid neoplasms following treatment for multiple myeloma-a single center analysis.

4. Racial differences as predictors of outcomes in young patients with multiple myeloma.

Review 5. Second primary malignancies in multiple myeloma: A review.

6. Induction of cell cycle arrest and apoptosis by CPUC002 through stabilization of p53 and suppression of STAT3 signaling pathway in multiple myeloma.

Second primary malignancies in multiple myeloma: an overview and IMWG consensus.

1. Selective targeting of multiple myeloma by B cell maturation antigen (BCMA)-specific central memory CD8+ cytotoxic T lymphocytes: immunotherapeutic application in vaccination and adoptive immunotherapy.

2. Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation-study on behalf of CMWP of the EBMT.

3. Therapy-related myeloid neoplasms following treatment for multiple myeloma-a single center analysis.

4. Racial differences as predictors of outcomes in young patients with multiple myeloma.

Review 5. Second primary malignancies in multiple myeloma: A review.

6. Induction of cell cycle arrest and apoptosis by CPUC002 through stabilization of p53 and suppression of STAT3 signaling pathway in multiple myeloma.

1. Selective targeting of multiple myeloma by B cell maturation antigen (BCMA)-specific central memory CD8⁺ cytotoxic T lymphocytes: immunotherapeutic application in vaccination and adoptive immunotherapy.